0001752724-22-155161.txt : 20220712 0001752724-22-155161.hdr.sgml : 20220712 20220712091629 ACCESSION NUMBER: 0001752724-22-155161 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20220430 FILED AS OF DATE: 20220712 DATE AS OF CHANGE: 20220712 EFFECTIVENESS DATE: 20220712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXCHANGE TRADED CONCEPTS TRUST CENTRAL INDEX KEY: 0001452937 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22263 FILM NUMBER: 221078336 BUSINESS ADDRESS: STREET 1: 10900 HEFNER POINTE DRIVE STREET 2: SUITE 400 CITY: OKLAHOMA CITY STATE: OK ZIP: 73120 BUSINESS PHONE: 405-778-8377 MAIL ADDRESS: STREET 1: 10900 HEFNER POINTE DRIVE STREET 2: SUITE 400 CITY: OKLAHOMA CITY STATE: OK ZIP: 73120 FORMER COMPANY: FORMER CONFORMED NAME: FAITHSHARES TRUST DATE OF NAME CHANGE: 20090717 FORMER COMPANY: FORMER CONFORMED NAME: FAITHSHARES INC DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: VERITAS FUNDS INC DATE OF NAME CHANGE: 20081230 0001452937 S000042659 ROBO Global(R) Robotics and Automation Index ETF C000131868 ROBO Global(R) Robotics and Automation Index ETF ROBO 0001452937 S000065729 ROBO Global(R) Artificial Intelligence ETF C000212574 ROBO Global(R) Artificial Intelligence ETF THNQ 0001452937 S000065730 ROBO Global(R) Healthcare Technology and Innovation ETF C000212575 ROBO Global(R) Healthcare Technology and Innovation ETF HTEC 0001452937 S000068816 Nifty India Financials ETF C000219897 Nifty India Financials ETF INDF N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001452937 XXXXXXXX 811-22263 N-1A S000065729 true S000068816 true S000042659 true S000065730 true EXCHANGE TRADED CONCEPTS TRUST 811-22263 0001452937 549300TXJW88BSB0KL90 10900 HEFNER POINTE DRIVE SUITE 400 OKLAHOMA CITY 73120 US-OK US 4057788377 SEI INVESTMENTS GLOBAL FUNDS SERVICES 1 Freedom Valley Drive OAKS 19456 610-676-1000 Records as Administrator for Trust BROWN BROTHERS HARRIMAN & CO. 40 Water Street Boston 02109 617-772-1818 Records as Custodian and Transfer Agent for Trust SEI INVESTMENTS DISTRIBUTION CO. 1 Freedom Valley Drive OAKS 19456 610-676-1000 Records as Distributor for Trust Exchange Traded Concepts, LLC 10900 Hefner Pointe Drive SUITE 400 Oklahoma City 73120 1-405-778-8377 Records as Advisor for Trust Bank of New York Mellon 240 Greenwich Street New York 10286 1-212-495-1784 Records as Custodian and Transfer Agent for Trust Vident Investment Advisory, LLC 300 Colonial Center Parkway Suite 330 Roswell 30076 1-404-487-1961 Records as sub-advisor for Trust N N N N-1A 20 Y Stuart Strauss N/A N J. Garrett Stevens N/A Y Linda Petrone N/A N Timothy Jacoby N/A N Mark Zurack N/A N Matthew B. Fleischer N/A 295 Madison Avenue 26th Floor New York 10017 XXXXXX Y N N N N N SEI INVESTMENTS DISTRIBTUION CO. 8-27897 000010690 N/A N N Cohen & Company, Ltd 925 N/A N N N N N N N Nifty India Financials ETF S000068816 5493002SQJ8SYE3VG403 N 1 0 0 Exchange-Traded Fund N N -0.67 -1.44 4.212755847 4.191902786 Y N N N N/A N/A N/A Rule 6c-11 (17 CFR 270.6c-11) Rule 32a-4 (17 CFR 270.32a-4) N N N N Exchange Traded Concepts, LLC 801-70485 000151197 549300BB5DRIKK8VVV91 N BROWN BROTHERS HARRIMAN & CO. 084-60256 5493006KMX1VFTPYPW14 N N N Pricing Direct 549300WIC0TOJ7N7GD54 N S&P 549300U4VWNITEKO2881 N Bloomberg 254900BF4G8VMW8GG471 N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Thomson Reuters Corporation 549300561UZND4C7B569 CA N IHS Markit 549300HLPTRASHS0E726 GB N N BROWN BROTHERS HARRIMAN & CO. 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N BROWN BROTHERS HARRIMAN & CO. 5493006KMX1VFTPYPW14 N N N SEI Investments Global Funds Services 801-24593 SEC File Number N N N SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 BTIG LLC 008-65473 000122225 549300GTG9PL6WO3EC51 709.71000000 ITG 008-44218 000029299 549300S41SMIODVIT266 4370.39999999 EFG CAPITAL (INSTANBUL) 8-48969 000040118 N/A 466.36000000 5546.46999999 0.00 N 8094610.83999999 N N N ROBO Global(R) Artificial Intelligence ETF S000065729 549300AO11OCTHSACQ26 N 1 0 0 Exchange-Traded Fund N N 0.28 -0.23 0.568241753 0.558341106 Y N Y N Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 6c-11 (17 CFR 270.6c-11) N N N N Exchange Traded Concepts LLC 801-70485 000151197 549300BB5DRIKK8VVV91 N The Bank of New York Mellon N/A HPFHU0OQ28E4N0NFVK49 N N N S&P 549300U4VWNITEKO2881 N Pricing Direct 549300WIC0TOJ7N7GD54 N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Thomson Reuters Corporation 549300561UZND4C7B569 CA N Bloomberg 254900BF4G8VMW8GG471 N IHS Markit 549300HLPTRASHS0E726 GB N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N SEI Investments Global Funds Services 801-24593 SEC File Number N N N SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 SOCIETE GENERALE COWEN SECURITIES CORP. 008-40756 000023857 5493008QI0EFC5WBED75 14.03 MISCHLER FINANCIAL 8-48067 000037818 2549004IPXPSM9EJFC92 6307.90 BTIG 008-65473 000122225 549300GTG9PL6WO3EC51 551.17 MORGAN STANLEY & CO, INC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 4.44 PERSHING LLC 008-17574 000007560 ZI8Q1A8EI8LQFJNM0D94 274.44 7151.98 0.00 N 38697982.44 N N N ROBO Global(R) Robotics and Automation Index ETF S000042659 549300DWX5221AQZYJ12 N 1 0 0 Exchange-Traded Fund N N 0.16 -0.59 0.145543864 0.135433905 Y N Y N N Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Administrative fee 221223912.00000000 2770141.67000000 Rule 32a-4 (17 CFR 270.32a-4) Rule 6c-11 (17 CFR 270.6c-11) N N N N Exchange Traded Concepts, LLC 801-70485 000151197 549300BB5DRIKK8VVV91 N Vident Investment Advisory, LLC 801-80534 000171004 254900XSZB691Z1A6X78 N N Bank of New York Mellon 085-05006 HPFHU0OQ28E4N0NFVK49 N N N Pricing Direct 549300WIC0TOJ7N7GD54 N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N S&P 549300U4VWNITEKO2881 N Bloomberg 254900BF4G8VMW8GG471 N IHS Markit 549300HLPTRASHS0E726 GB N Thomson Reuters Corporation 549300561UZND4C7B569 CA N N SKANDINAVISKA ENSKILDA BANKEN, STOCKHOLM N/A SE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) BANK HAPOALIM B.M. N/A IL N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HSBC BANK (TAIWAN) LIMITED N/A TW N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CIBC MELLON TRUST COMPANY N/A CA N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) EUROCLEAR BANK, BRUSSELS N/A BE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON SA/NV, ASSET SERVICING, NIEDERLASSUNG FRANKFURT AM MAIN N/A DE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) THE BANK OF NEW YORK MELLON SA/NV N/A NL N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CREDIT SUISSE (SWITZERLAND) LTD (T2S) N/A CH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) SKANDINAVISKA ENSKILDA BANKEN, HELSINKI BRANCH N/A FI N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) DEUTSCHE BANK-SEOUL BRANCH N/A KR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A NL N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HSBC SHANGHAI-HONG KONG STOCK CONNECT SPSA N/A HK N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CREDIT SUISSE (SWITZERLAND) LTD N/A CH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) ESES FRANCE REGISTERED N/A FR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A FI N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HONGKONG AND SHANGHAI BANKING CORPORATION, HONG KONG N/A HK N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A FR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) ESES FRANCE BEARER N/A FR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A GB N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) MUFG BANK, LTD N/A JP N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) SKANDINAVISKA ENSKILDA BANKEN AB, OSLO BRANCH N/A NO N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) THE BANK OF NEW YORK MELLON N/A DE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N SEI Investments Global Funds Services 801-24593 SEC File Number N N N SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 BAML 008-69787 000283942 549300HN4UKV1E2R3U73 1068.05000000 JANE STREET EXECUTION SERVICES 8-69254 000167280 549300HXJLXCPDWAH070 40274.61999999 UBS SECURITIES 008-22651 000007654 T6FIZBDPKLYJKFCRVK44 46129.90999999 GOLDMAN SACHS & CO 008-00129 000000361 FOR8UP27PHTHYVLBNG30 76663.01000000 BTIG LLC 008-65473 000122225 549300GTG9PL6WO3EC51 123953.56000000 VIRTU FINANCIAL BD LLC 8-60815 000148390 54930088MP91YZQJT494 9819.55000000 JPM CHASE 008-35008 000000079 ZBUT11V806EZRVTWT807 9051.64000000 IMPERIAL CAPITAL 008-50397 000043744 549300I8X15KSI64Y307 44454.64000000 351414.98000000 0.00 N 1794942150.58999990 N N N ROBO Global(R) Healthcare Technology and Innovation ETF S000065730 549300DWX5221AQZYJ12 N 1 0 0 Exchange-Traded Fund N N 0.08 -0.37 0.188904394 0.162574942 Y N Y N Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 6c-11 (17 CFR 270.6c-11) N N N N Exchange Traded Concepts, LLC 801-70485 000151197 549300BB5DRIKK8VVV91 N Bank of New York Mellon 085-05006 HPFHU0OQ28E4N0NFVK49 N N N IHS Markit 549300HLPTRASHS0E726 GB N Pricing Direct 549300WIC0TOJ7N7GD54 N S&P 549300U4VWNITEKO2881 N Thomson Reuters Corporation 549300561UZND4C7B569 CA N Bloomberg 254900BF4G8VMW8GG471 N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N N Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N SEI Investments Global Funds Services 801-24593 SEC File Number N N N SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 BTIG 008-65473 000122225 549300GTG9PL6WO3EC51 37037.10000000 MISCHLER FINANCIAL 8-48067 000037818 2549004IPXPSM9EJFC92 11572.84999999 48609.95000000 0.00 N 210905988.33000001 N N N Nifty India Financials ETF S000068816 N 25000.00000000 100.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 1000.00000000 0.00000000 0.00000000 1000.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N ROBO Global(R) Artificial Intelligence ETF S000065729 Y 25000.00000000 6.39948849 0.74829439 93.60051150 0.74829439 13.42815547 6.72560460 86.57184452 6.72560460 0.00000000 366.66666666 0.00000000 0.00000000 366.66666666 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 Y ROBO Global(R) Robotics and Automation Index ETF S000042659 Y 50000.00000000 8.85742842 1.88823156 91.14257157 1.88823156 7.30265946 2.56518037 92.69734053 2.56518037 0.00000000 900.00000000 0.00000000 0.00000000 900.00000000 0.00000000 0.00000000 851.85185185 0.00000000 0.00000000 851.85185185 0.00000000 Y ROBO Global(R) Healthcare Technology and Innovation ETF S000065730 Y 25000.00000000 1.50716723 1.18195732 98.49283276 1.18195732 2.11654574 2.34103897 97.88345425 2.34103897 0.00000000 471.42857142 0.00000000 0.00000000 366.66666666 0.00000000 0.00000000 412.50000000 0.00000000 0.00000000 0.00000000 0.00000000 Y false false true false false false INTERNAL CONTROL RPT 2 ROBO_ICL.txt INTERNAL CONTROL LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders of ROBO Global Healthcare Technology and Innovation ETF, ROBO Global Robotics and Automation Index ETF, and ROBO Global Artificial Intelligence ETF and Board of Trustees of Exchange Traded Concepts Trust In planning and performing our audit of the financial statements of ROBO Global Healthcare Technology and Innovation ETF, ROBO Global Robotics and Automation Index ETF, and ROBO Global Artificial Intelligence ETF (the Funds), each a series of Exchange Traded Concepts Trust, as of and for the year ended April 30, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion. The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A funds internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A funds internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a funds assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of April 30, 2022. This report is intended solely for the information and use of management and the Board of Trustees of the Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. COHEN & COMPANY, LTD. Cleveland, Ohio June 29, 2022 INTERNAL CONTROL RPT 3 INDF_ICL.txt INTERNAL CONTROL LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders of Nifty India Financials ETF and Board of Trustees of Exchange Traded Concepts Trust In planning and performing our audit of the financial statements of Nifty India Financials ETF (the Fund), a series of Exchange Traded Concepts Trust, as of and for the year ended April 30, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A funds internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A funds internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a funds assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of April 30, 2022. This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. COHEN & COMPANY, LTD. Cleveland, Ohio June 29, 2022